176 related articles for article (PubMed ID: 22329983)
1. Myocardial protection in beating heart cardiac surgery: I: pre- or postconditioning with inhibition of es-ENT1 nucleoside transporter and adenosine deaminase attenuates post-MI reperfusion-mediated ventricular fibrillation and regional contractile dysfunction.
Abd-Elfattah AS; Aly H; Hanan S; Wechsler AS
J Thorac Cardiovasc Surg; 2012 Jul; 144(1):250-5. PubMed ID: 22329983
[TBL] [Abstract][Full Text] [Related]
2. Hot shot induction and reperfusion with a specific blocker of the es-ENT1 nucleoside transporter before and after hypothermic cardioplegia abolishes myocardial stunning in acutely ischemic hearts despite metabolic derangement: hot shot drug delivery before hypothermic cardioplegia.
Abd-Elfattah AS; Tuchy GE; Jessen ME; Salter DR; Goldstein JP; Brunsting LA; Wechsler AS
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):961-970.e3. PubMed ID: 23422047
[TBL] [Abstract][Full Text] [Related]
3. Intermittent aortic crossclamping prevents cumulative adenosine triphosphate depletion, ventricular fibrillation, and dysfunction (stunning): is it preconditioning?
Abd-Elfattah AS; Ding M; Wechsler AS
J Thorac Cardiovasc Surg; 1995 Aug; 110(2):328-39. PubMed ID: 7637350
[TBL] [Abstract][Full Text] [Related]
4. On-pump inhibition of es-ENT1 nucleoside transporter and adenosine deaminase during aortic crossclamping entraps intracellular adenosine and protects against reperfusion injury: role of adenosine A1 receptor.
Abd-Elfattah AS; Ding M; Jessen ME; Wechsler AS
J Thorac Cardiovasc Surg; 2012 Jul; 144(1):243-9. PubMed ID: 22325325
[TBL] [Abstract][Full Text] [Related]
5. Nucleoside trapping during reperfusion prevents ventricular dysfunction, "stunning," in absence of adenosine. Possible separation between ischemic and reperfusion injury.
Abd-Elfattah AS; Jessen ME; Wechsler AS
J Thorac Cardiovasc Surg; 1994 Aug; 108(2):269-78. PubMed ID: 8041175
[TBL] [Abstract][Full Text] [Related]
6. Separation between ischemic and reperfusion injury by site specific entrapment of endogenous adenosine and inosine using NBMPR and EHNA.
Abd-Elfattah AS; Wechsler AS
J Card Surg; 1994 May; 9(3 Suppl):387-96. PubMed ID: 8069025
[TBL] [Abstract][Full Text] [Related]
7. Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury.
Abd-Elfattah AS; Jessen ME; Lekven J; Wechsler AS
Mol Cell Biochem; 1998 Mar; 180(1-2):179-91. PubMed ID: 9546645
[TBL] [Abstract][Full Text] [Related]
8. Protection of the stunned myocardium. Selective nucleoside transport blocker administered after 20 minutes of ischemia augments recovery of ventricular function.
Abd-Elfattah AS; Ding M; Dyke CM; Wechsler AS
Circulation; 1993 Nov; 88(5 Pt 2):II336-43. PubMed ID: 8222175
[TBL] [Abstract][Full Text] [Related]
9. Is adenosine 5'-triphosphate derangement or free-radical-mediated injury the major cause of ventricular dysfunction during reperfusion? Role of adenine nucleoside transport in myocardial reperfusion injury.
Abd-Elfattah AS; Jessen ME; Hanan SA; Tuchy G; Wechsler AS
Circulation; 1990 Nov; 82(5 Suppl):IV341-50. PubMed ID: 2225426
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of endogenous adenosine attenuates myocardial 'stunning' independently of coronary flow or hemodynamic effects.
Zughaib ME; Abd-Elfattah AS; Jeroudi MO; Sun JZ; Sekili S; Tang XL; Bolli R
Circulation; 1993 Nov; 88(5 Pt 1):2359-69. PubMed ID: 8222129
[TBL] [Abstract][Full Text] [Related]
11. Role of nucleoside transport and purine release in a rabbit model of myocardial stunning.
Abd-Elfattah AS; Maddox RP; Jessen ME; Rebeyka IM; Wechsler AS
Mol Cell Biochem; 1998 Mar; 180(1-2):145-51. PubMed ID: 9546641
[TBL] [Abstract][Full Text] [Related]
12. Myocardial reperfusion injury. Role of myocardial hypoxanthine and xanthine in free radical-mediated reperfusion injury.
Abd-Elfattah AS; Jessen ME; Lekven J; Doherty NE; Brunsting LA; Wechsler AS
Circulation; 1988 Nov; 78(5 Pt 2):III224-35. PubMed ID: 3180402
[TBL] [Abstract][Full Text] [Related]
13. Combined remote perconditioning and postconditioning failed to attenuate infarct size and contractile dysfunction in a rat model of coronary artery occlusion.
Sachdeva J; Dai W; Gerczuk PZ; Kloner RA
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):567-73. PubMed ID: 24607766
[TBL] [Abstract][Full Text] [Related]
14. Cardiac protection by ischaemic preconditioning is not mediated by myocardial stunning.
Matsuda M; Catena TG; Vander Heide RS; Jennings RB; Reimer KA
Cardiovasc Res; 1993 Apr; 27(4):585-92. PubMed ID: 8324790
[TBL] [Abstract][Full Text] [Related]
15. Preconditioning does not attenuate myocardial stunning.
Ovize M; Przyklenk K; Hale SL; Kloner RA
Circulation; 1992 Jun; 85(6):2247-54. PubMed ID: 1591839
[TBL] [Abstract][Full Text] [Related]
16. [Adenosine deaminase inhibitor (EHNA) on ischemia-reperfusion injury in isolated perfused rat hearts].
Zhu Q
Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Apr; 18(2):107-9, 127. PubMed ID: 2209402
[TBL] [Abstract][Full Text] [Related]
17. Monophosphoryl lipid A attenuates myocardial stunning in dogs: role of ATP-sensitive potassium channels.
Elliott GT; Mei DA; Gross GJ
J Cardiovasc Pharmacol; 1998 Jul; 32(1):49-56. PubMed ID: 9676720
[TBL] [Abstract][Full Text] [Related]
18. Postischemic cardiac function recovery in the isolated rat heart: effects of adenosine deaminase and nucleoside transport inhibition.
Keeling IM; Obermayr RP; Schneider B; Spieckermann PG
Langenbecks Arch Surg; 2000 Dec; 385(8):531-7. PubMed ID: 11201010
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia.
Glover DK; Ruiz M; Takehana K; Petruzella FD; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3164-71. PubMed ID: 17308004
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels.
Kersten JR; Schmeling TJ; Hettrick DA; Pagel PS; Gross GJ; Warltier DC
Anesthesiology; 1996 Oct; 85(4):794-807; discussion 27A. PubMed ID: 8873550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
